Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhibitory activity of cefotetan and other beta-lactams against anaerobes.

× No keyword cloud information.

9 in total

1. Toxicity and clearance of intravitreal cefotetan.

Authors: W Philipp; K Schmid; H J Steiner; B Pümpel; F Allerberger; H P Aichberger; W Mayer
Journal: Graefes Arch Clin Exp Ophthalmol Date: 1990 Impact factor: 3.117

2. Intraperitoneal penetration of cefotetan.

Authors: R Wise; I A Donovan; J Drumm; J Dent; S A Bennett
Journal: Antimicrob Agents Chemother Date: 1983-08 Impact factor: 5.191

3. In vitro activity of flomoxef in comparison to other cephalosporins.

Authors: C Simon; M Simon; C Plieth
Journal: Infection Date: 1988 Mar-Apr Impact factor: 3.553

4. Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.

Authors: C Betriu; E Campos; C Cabronero; C Rodriguez-Avial; J J Picazo
Journal: Antimicrob Agents Chemother Date: 1990-04 Impact factor: 5.191

5. Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.

Authors: P C Appelbaum; S K Spangler; M R Jacobs
Journal: Antimicrob Agents Chemother Date: 1991-06 Impact factor: 5.191

6. In vitro activity of cefmetazole, cefotetan, amoxicillin-clavulanic acid, and other antimicrobial agents against anaerobic bacteria from endometrial cultures of women with pelvic infections.

Authors: M J Ohm-Smith; R L Sweet
Journal: Antimicrob Agents Chemother Date: 1987-09 Impact factor: 5.191

Inhibitory activity of cefotetan and other beta-lactams against anaerobes.

1. Toxicity and clearance of intravitreal cefotetan.

2. Intraperitoneal penetration of cefotetan.

3. In vitro activity of flomoxef in comparison to other cephalosporins.

4. Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.

5. Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.

6. In vitro activity of cefmetazole, cefotetan, amoxicillin-clavulanic acid, and other antimicrobial agents against anaerobic bacteria from endometrial cultures of women with pelvic infections.

Review 7. Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

8. In vitro activity of cefotetan compared with that of other antimicrobial agents against anaerobic bacteria.

9. In vitro activity of ampicillin plus sulbactam against anaerobes compared to ampicillin and cefoxitin.